Patents Assigned to University of Dundee
-
Publication number: 20170342036Abstract: The present invention relates to the discovery that salt inducible kinases (SIKs) suppress the formation of anti-inflammatory molecules such as IL-10, which are important for the resolution of inflammation and identifies SIK inhibitors that may be used to treat disorders associated with undesirable inflammation, such as inflammatory bowel disease and/or autoimmune disorders.Type: ApplicationFiled: May 26, 2017Publication date: November 30, 2017Applicants: Dana-Farber Cancer Institute, Inc., University Court of the University of DundeeInventors: Philip Cohen, Kristopher Clark, Hwan Geun Choi, Nathanael S. Gray
-
Patent number: 9828346Abstract: The present invention relates to N-heterocyclic sulphonamide compounds, in particular pyrazole sulphonamide compounds, and their use as N-myristoyl transferase inhibitors.Type: GrantFiled: August 31, 2015Date of Patent: November 28, 2017Assignee: University of DundeeInventors: Stephen Brand, Paul Wyatt, Stephen Thompson, Victoria Smith, Tracy Bayliss, Justin Harrison, Neil Norcross, Laura Cleghorn, Ian Gilbert, Ruth Brenk
-
Patent number: 9801655Abstract: A device for creating an intercostal transcutaneous access to an, in particular endoscopic, operating field including a base body, which closely surrounds an incision all-side frame-shaped and with at least two webs mounted on the base body, which can be introduced into an intercostal space, by which two ribs arranged next to each other can be moved apart. To create a device for creating an intercostal transcutaneous access to an, in particular endoscopic, operating field which allows individual pressing apart of the ribs, it is proposed according to the invention that the at least two webs are mounted adjustable relative to each other on the base body.Type: GrantFiled: September 12, 2014Date of Patent: October 31, 2017Assignee: University of DundeeInventors: Alfred Cuschieri, Stuart Coleman, Duncan Martin
-
Patent number: 9670165Abstract: The present invention relates to the discovery that salt inducible kinases (SIKs) suppress the formation of anti-inflammatory molecules such as IL-10, which are important for the resolution of inflammation and identifies SIK inhibitors that may be used to treat disorders associated with undesirable inflammation, such as inflammatory bowel disease and/or autoimmune disorders.Type: GrantFiled: March 13, 2013Date of Patent: June 6, 2017Assignees: Dana-Farber Cancer Institute, Inc., University Court of the University of DundeeInventors: Philip Cohen, Kristopher Clark, Hwan Geun Choi, Nathanael Gray
-
Patent number: 9585550Abstract: There is disclosed medical apparatus of the type for use in surgery such as transanal endoscopic microsurgery, as well as methods of providing access to, inspecting and enabling surgery within a body passage. In one embodiment of the invention, medical apparatus in the form of a rectal expander (10) is disclosed, the expander (10) being adapted for location at least partly within a body passage such as the rectum (12) of a patient (14), the expander (10) having a leading end (18) and an access area in the form of an opening (20) for access from the expander (10) into the rectum (12), at least part of the opening (20) being spaced from the leading end (18), and the expander (10) being controllably movable between collapse and expansion positions, for expanding the rectum (12).Type: GrantFiled: June 24, 2004Date of Patent: March 7, 2017Assignee: University of DundeeInventors: Eric Abel, James R. Hewit, Alan P. Slade, Zhigang Wang
-
Publication number: 20170051729Abstract: An actuator (12) includes a moving member (18) pivotally connected to a base unit (14) for rotation about an axis. The driving force for rotation of the moving member (18) relative to the base unit (14) is provided by a pair of antagonistically operating shape memory alloy (SMA) wires (48, 50) and transmitted via a torsional spring (56). An endoscope, or a snake-like robot (66), may include one or more of the actuators (12).Type: ApplicationFiled: April 23, 2015Publication date: February 23, 2017Applicant: University of DundeeInventors: Luigi Manfredi, Alfred Cuschieri
-
Publication number: 20170050881Abstract: A method for welding together glass workpieces where one of the workpieces has metal nanoparticles positioned at or near the surface to be welded. The method comprises positioning the workpieces in operative contact at an interface where a weld is to be formed, applying a laser beam to be incident upon the interface wherein energy from the laser beam is absorbed by the nanoparticle bearing workpiece and the energy from the laser beam is transferred to the glass surrounding the metal nanoparticles to heat the glass and to weld the workpieces together.Type: ApplicationFiled: January 27, 2015Publication date: February 23, 2017Applicant: The University of DundeeInventor: Amin Abdolvand
-
Patent number: 9454060Abstract: A mode locked semiconductor disk laser with an output beam having an ultra-short pulse length which provides the incident beam to a non linear microscope. The wavelength of the beam is at or near the action cross section maximum absorption wavelength for creating two photon excited fluorescence of a fluorescent biological marker in a sample. Semiconductor disk lasers combine excellent beam quality and output power, stability while maintaining simplicity and easiness of operation. In addition, these types of lasers are ideally suited for mass production as they are built in wafer-scale technology enabling a high level of integration. Importantly this non expensive, turn-key, compact laser system could be used as a platform to develop portable non-linear bio-imaging devices for clinical studies, facilitating its wide-spread adoption in “real-life” applications.Type: GrantFiled: September 19, 2011Date of Patent: September 27, 2016Assignee: The University of DundeeInventors: Craig Hamilton, Graeme Malcolm, Ursula Keller, Thomas Sudmeyer, Kurt Weingarten, Pablo Loza-Alvarez, Yohan Barbarin, Edik Rafailov
-
Patent number: 9365508Abstract: The invention provides compounds according to formula (I): (wherein X, Y, Z1 R1, R2, R3, Ar and Ar? are as defined herein), and physiologically acceptable salts, solvates, esters or amides thereof, pharmaceutical compositions comprising these compounds and the compounds for use in medicine, for example for the treatment or prophylaxis of diseases involving cell proliferation, such as cancer, and for the treatment or prophylaxis of other diseases.Type: GrantFiled: June 9, 2010Date of Patent: June 14, 2016Assignees: University Court of the University of St Andrews, University Court of the University of DundeeInventors: Sonia Lain, Nicholas James Westwood, David Philip Lane
-
Publication number: 20160095823Abstract: The present invention concerns compounds derived from the anaesthetic propofol that are useful as analgesics and methods of using the same. The compounds act as co-activators of strychnine-sensitive glycine receptors and may have greater activity at those glycine receptors than at GABAA.Type: ApplicationFiled: November 24, 2015Publication date: April 7, 2016Applicants: The University of Liverpool, The University of Dundee, Medizinische Hochschule HannoverInventors: Martin Leuwer, Gertrud Haeseler, Jeremy Lambert, Delia Belelli
-
Patent number: 9265826Abstract: The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.Type: GrantFiled: March 12, 2013Date of Patent: February 23, 2016Assignee: University Court of the University of DundeeInventors: Paul Richard Crocker, Bjoern Biedermann, David Bowen
-
Publication number: 20160000908Abstract: The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.Type: ApplicationFiled: March 12, 2013Publication date: January 7, 2016Applicant: University Court of the University of DundeeInventors: Paul Richard Crocker, Bjoern Biedermann, David Bowen
-
Patent number: 9229939Abstract: A system for arranging searchable items, such as digital images or multimedia icons for presentation on a graphical user interface. The system has an optimizer module which minimizes a cost function for arranging items in a layout space and is applied to one or more predetermined characteristics of the items. The optimizer module also creates a mixture distribution by considering each item as having a spatial distribution in the layout space and controls the entropy of the mixture distribution in order to maximize the extent to which each item occupies a separate position in the layout space. A Renderer module then renders the layouts to generate a display.Type: GrantFiled: January 28, 2010Date of Patent: January 5, 2016Assignee: The University of DundeeInventors: Stephen McKenna, Ruixuan Wang, Annette Ward
-
Patent number: 9155289Abstract: Non-human animals which overexpress PPARd or which express transgenic PPARd are useful as models for inflammatory skin conditions such as psoriasis. Test substances can be screened to assess their suitability for the treatment of inflammatory skin conditions such as psoriasis. Methyl 3-({[2-(methoxy)-4-phenyl]amino}sulfonyl)-2-thiophenecarboxylate can be administered topically for the prevention or treatment of psoriasis.Type: GrantFiled: July 31, 2009Date of Patent: October 13, 2015Assignee: University Court of the University of DundeeInventors: Colin Palmer, John Foerster, Nainamalai Sitherswaran
-
Patent number: 9120765Abstract: The present invention relates to compounds which activate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions involving sirtuin function.Type: GrantFiled: May 3, 2013Date of Patent: September 1, 2015Assignees: University Court of the University of Dundee, University Court of the University of St. AndrewsInventors: Sonia Lain, David Phillip Lane, Michael John Raymond Stark, Anna Rose McCarthy, Jonathan James Hollick, Nicholas James Westwood
-
Patent number: 9101345Abstract: A surgical tissue anchor comprising a plurality of jaws suitable for clamping onto tissue, clamp component(s) operable to bias the jaws in a closed position and attachment structure operable for attachment of the anchor to one or more tethers for retracting the clamped tissue. The one or more tethers are guided to the desired region using a surgical guide.Type: GrantFiled: January 19, 2012Date of Patent: August 11, 2015Assignee: The University of DundeeInventors: Stuart Ian Brown, Stuart Coleman, Alfred Cuschieri, Leslie Kelly, Paul Simon Maher, James Duncan Shaw Martin
-
Patent number: 9079895Abstract: The invention relates to morpholino-derivatives according to Formula (I) or stereoisomers or pharmaceutically acceptable salts or solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, m and n are as defined in the specification. The compounds are antagonists, reverse agonists or agonists of G-protein coupled receptors, such as dopamine D4 and 5HT1a. The inventions also relates to pharmaceutical compositions comprising the compounds and methods involving the compounds and compositions. The compounds and compositions of the invention may in particular be used in the treatment of diseases and disorders, such as neurological and neurodegenerative diseases; or as lead compounds for the design and selection of further therapeutic compounds.Type: GrantFiled: November 20, 2013Date of Patent: July 14, 2015Assignee: University of DundeeInventors: Jeremy Besnard, Andrew Lee Hopkins, Ian Gilbert, Gian Filippo Ruda, Keren Abecassis
-
Patent number: 9068165Abstract: The present invention provides methods and compositions for modulating cell senescence and cell proliferation using isoforms of the p53 tumor suppressor protein. The methods and compositions of the invention find use in inhibiting cancer cell growth or in generating populations of cells for tissue regeneration through the modulation of cell senescence and proliferation.Type: GrantFiled: July 26, 2013Date of Patent: June 30, 2015Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, The University of Dundee, Masaryk Memorial Cancer InstituteInventors: Curtis C. Harris, Kaori Fujita, Izumi Horikawa, Borivoj Vojtesek, Jean-Christophe Bourdon, David P. Lane
-
Publication number: 20150104806Abstract: The present invention relates to a biomarker for Parkinson's disease. The biomarker and products associated with the biomarker may be used to assist diagnosis or to assess onset and/or development of Parkinson's disease. The invention also relates to use of the biomarker in clinical screening, assessment of prognosis, evaluation of drug treatments, drug screening or drug development in the field of Parkinson's disease and Parkinson's disease related disorders.Type: ApplicationFiled: April 10, 2013Publication date: April 16, 2015Applicant: University of DundeeInventors: Dario Alessi, Muratul Muqit
-
Patent number: 8999635Abstract: The present invention relates to the identification of loss-of-function mutations in the filaggrin gene and their use in diagnosing ichthyosis vulgaris and/or susceptibility to other diseases including atopic dermatitis (eczema), asthma, psoriasis and allergies (including food allergy).Type: GrantFiled: December 15, 2006Date of Patent: April 7, 2015Assignee: University Court of The University of DundeeInventors: William Henry Irwin McLean, Frances Jane Dorothy Smith